299 related articles for article (PubMed ID: 21656246)
1. Comparison of the myocardial blood flow response to regadenoson and dipyridamole: a quantitative analysis in patients referred for clinical 82Rb myocardial perfusion PET.
Goudarzi B; Fukushima K; Bravo P; Merrill J; Bengel FM
Eur J Nucl Med Mol Imaging; 2011 Oct; 38(10):1908-16. PubMed ID: 21656246
[TBL] [Abstract][Full Text] [Related]
2. Comparison and effectiveness of regadenoson versus dipyridamole on stress electrocardiographic changes during positron emission tomography evaluation of patients with hypertrophic cardiomyopathy.
Bravo PE; Pozios I; Pinheiro A; Merrill J; Tsui BM; Wahl RL; Bengel FM; Abraham MR; Abraham TP
Am J Cardiol; 2012 Oct; 110(7):1033-9. PubMed ID: 22748357
[TBL] [Abstract][Full Text] [Related]
3. Regadenoson versus dipyridamole: Evaluation of stress myocardial blood flow response on a CZT-SPECT camera.
Brana Q; Thibault F; Courtehoux M; Metrard G; Ribeiro MJ; Angoulvant D; Bailly M
J Nucl Cardiol; 2022 Feb; 29(1):113-122. PubMed ID: 32651801
[TBL] [Abstract][Full Text] [Related]
4. Regadenoson and adenosine are equivalent vasodilators and are superior than dipyridamole- a study of first pass quantitative perfusion cardiovascular magnetic resonance.
Vasu S; Bandettini WP; Hsu LY; Kellman P; Leung S; Mancini C; Shanbhag SM; Wilson J; Booker OJ; Arai AE
J Cardiovasc Magn Reson; 2013 Sep; 15(1):85. PubMed ID: 24063278
[TBL] [Abstract][Full Text] [Related]
5. Effect of Outflow Tract Contributions to 82Rb-PET Global Myocardial Blood Flow Computations.
Van Tosh A; Reichek N; Palestro CJ; Nichols KJ
J Nucl Med Technol; 2016 Jun; 44(2):78-84. PubMed ID: 26966126
[TBL] [Abstract][Full Text] [Related]
6. Regadenoson versus dipyridamole hyperemia for cardiac PET imaging.
Johnson NP; Gould KL
JACC Cardiovasc Imaging; 2015 Apr; 8(4):438-447. PubMed ID: 25797122
[TBL] [Abstract][Full Text] [Related]
7. Impact of regadenoson-induced myocardial creep on dynamic Rubidium-82 PET myocardial blood flow quantification.
Koenders SS; van Dijk JD; Jager PL; Ottervanger JP; Slump CH; van Dalen JA
J Nucl Cardiol; 2019 Jun; 26(3):719-728. PubMed ID: 30788758
[TBL] [Abstract][Full Text] [Related]
8. Left ventricular ejection fraction, myocardial blood flow and hemodynamic variables in adenosine and regadenoson vasodilator 82-Rubidium PET.
Frey SM; Honegger U; Clerc OF; Caobelli F; Haaf P; Zellweger MJ
J Nucl Cardiol; 2022 Jun; 29(3):921-933. PubMed ID: 34386864
[TBL] [Abstract][Full Text] [Related]
9. Regadenoson pharmacologic rubidium-82 PET: a comparison of quantitative perfusion and function to dipyridamole.
Cullom SJ; Case JA; Courter SA; McGhie AI; Bateman TM
J Nucl Cardiol; 2013 Feb; 20(1):76-83. PubMed ID: 23188625
[TBL] [Abstract][Full Text] [Related]
10. Impaired global myocardial flow dynamics despite normal left ventricular function and regional perfusion in chronic kidney disease: a quantitative analysis of clinical 82Rb PET/CT studies.
Fukushima K; Javadi MS; Higuchi T; Bravo PE; Chien D; Lautamäki R; Merrill J; Nekolla SG; Bengel FM
J Nucl Med; 2012 Jun; 53(6):887-93. PubMed ID: 22562499
[TBL] [Abstract][Full Text] [Related]
11. Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics.
Mekkaoui C; Jadbabaie F; Dione DP; Meoli DF; Purushothaman K; Belardinelli L; Sinusas AJ
JACC Cardiovasc Imaging; 2009 Oct; 2(10):1198-208. PubMed ID: 19833310
[TBL] [Abstract][Full Text] [Related]
12. Detection of obstructive coronary artery disease using regadenoson stress and 82Rb PET/CT myocardial perfusion imaging.
Hsiao E; Ali B; Blankstein R; Skali H; Ali T; Bruyere J; Kwong RY; Di Carli MF; Dorbala S
J Nucl Med; 2013 Oct; 54(10):1748-54. PubMed ID: 23940305
[TBL] [Abstract][Full Text] [Related]
13. Quantitative myocardial perfusion positron emission tomography and caffeine revisited with new insights on major adverse cardiovascular events and coronary flow capacity.
Kitkungvan D; Bui L; Johnson NP; Patel MB; Roby AE; Vejpongsa P; Babar AK; Madjid M; Nacimbene A; Kumar S; DeGolovine A; Gould KL
Eur Heart J Cardiovasc Imaging; 2019 Jul; 20(7):751-762. PubMed ID: 31056681
[TBL] [Abstract][Full Text] [Related]
14. The effect of obesity on regadenoson-induced myocardial hyperemia: a quantitative magnetic resonance imaging study.
DiBella EV; Fluckiger JU; Chen L; Kim TH; Pack NA; Matthews B; Adluru G; Priester T; Kuppahally S; Jiji R; McGann C; Litwin SE
Int J Cardiovasc Imaging; 2012 Aug; 28(6):1435-44. PubMed ID: 21968545
[TBL] [Abstract][Full Text] [Related]
15. Myocardial perfusion imaging laboratory efficiency with the use of regadenoson compared to adenosine and dipyridamole.
Friedman M; Spalding J; Kothari S; Wu Y; Gatt E; Boulanger L
J Med Econ; 2013; 16(4):449-60. PubMed ID: 23363331
[TBL] [Abstract][Full Text] [Related]
16. Regadenoson versus Dipyridamole: A Comparison of the Frequency of Adverse Events in Patients Undergoing Myocardial Perfusion Imaging.
Amer KA; Hurren JR; Edwin SB; Cohen G
Pharmacotherapy; 2017 Jun; 37(6):657-661. PubMed ID: 28475259
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two dipyridamole infusion protocols for myocardial perfusion imaging in subjects with low likelihood of significant obstructive coronary artery disease.
Harel F; Finnerty V; Authier S; Pelletier-Galarneau M
J Nucl Cardiol; 2020 Oct; 27(5):1820-1828. PubMed ID: 30367380
[TBL] [Abstract][Full Text] [Related]
18. Cardiac Displacement During
Vleeming EJ; Lazarenko SV; van der Zant FM; Pan XB; Declerck JM; Wondergem M; Knol RJJ
J Nucl Med Technol; 2018 Jun; 46(2):114-122. PubMed ID: 29273695
[TBL] [Abstract][Full Text] [Related]
19. [Regadenoson as a new stress agent in myocardial perfusion imaging. Initial experience in The Netherlands].
Jager PL; Buiting M; Mouden M; Oostdijk AH; Timmer J; Knollema S
Rev Esp Med Nucl Imagen Mol; 2014; 33(6):346-51. PubMed ID: 24862658
[TBL] [Abstract][Full Text] [Related]
20. Dependency of cardiac rubidium-82 imaging quantitative measures on age, gender, vascular territory, and software in a cardiovascular normal population.
Sunderland JJ; Pan XB; Declerck J; Menda Y
J Nucl Cardiol; 2015 Feb; 22(1):72-84. PubMed ID: 25294436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
